{"id":"NCT01042977","sponsor":"AstraZeneca","briefTitle":"Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease","officialTitle":"A 24-week, Multicentre, Randomised, Double-blind,Age-stratified, Placebo Controlled Phase III Study With an 80-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin 10 mg Once Daily in Patients With T2DM and Cardiovascular Disease, Who Exhibit Inadequate Glycaemic Control on Usual Care","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-03","primaryCompletion":"2011-05","completion":"2012-12","firstPosted":"2010-01-06","resultsPosted":"2013-08-23","lastUpdate":"2014-02-17"},"enrollment":964,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus","Cardiovascular Disease","Inadequate Glycaemic Control"],"interventions":[{"type":"DRUG","name":"Dapagliflozin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"This study is carried out to assess whether dapagliflozin improves glycemic control, decreases fasting plasma glucose levels, body weight and blood pressure when added to patient's existing medications and how it compares with their usual treatment without added dapagliflozin. Safety data will be collected and analysed to confirm that treatment with dapagliflozin is safe and well tolerated in patients who have diabetes and cardiovascular disease","primaryOutcome":{"measure":"Adjusted Mean Change in HbA1c Levels","timeFrame":"Baseline to Week 24","effectByArm":[{"arm":"Dapagliflozin","deltaMin":-0.33,"sd":0.0434},{"arm":"Placebo","deltaMin":0.07,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"45 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":135,"countries":["United States","Argentina","Australia","Austria","Bulgaria","Canada","Chile","Germany","Hungary","Poland"]},"refs":{"pmids":["38770818"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":41,"n":482},"commonTop":["Hypoglycemia","Nasopharyngitis","Urinary tract infection","Upper respiratory tract infection"]}}